Low Vitamin D levels associated with low COVID-19 vaccine antibody titers among adults

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-09-13 04:15 GMT   |   Update On 2024-02-12 19:38 GMT

Researchers have found in a new study that adults with vitamin D deficiency had lower COVID-19 vaccine antibody titers than those with normal vitamin D levels 9 months after vaccination. However, there were no differences in antibody levels found at 1 and 5 months. The report has been published in the Endocrine.Low vitamin D levels were reported to negatively influence the outcome of...

Login or Register to read the full article

Researchers have found in a new study that adults with vitamin D deficiency had lower COVID-19 vaccine antibody titers than those with normal vitamin D levels 9 months after vaccination. However, there were no differences in antibody levels found at 1 and 5 months. The report has been published in the Endocrine.

Low vitamin D levels were reported to negatively influence the outcome of acute COVID-19, as well as to be linked to Long-COVID. However, few studies have investigated, so far, its effects on humoral-response to anti-SARS-CoV-2 vaccination, reporting conflicting results. We aimed to evaluate the impact of baseline 25(OH)vitamin D (25(OH)D) levels on humoral-response to a two-dose cycle of Pfizer-BioNTech-vaccine up to 9–10 months after immunization.

Researchers retrospectively included 119 consecutive healthcare-workers (median age 53 years) without a previous history of acute COVID-19 or anti-SARS-CoV-2 immunoglobulins presence immunized with two doses of Comirnaty-vaccine from January to February 2021. 25(OH)D was measured at time of first-immunization. Immune response was evaluated at: time 0 (T0), before the first-dose; T1, time of second-dose (21 days after T0); T2, T3, T4 at 1, 5 and 9 months after T1, respectively.

Results

Median 25(OH)D levels were 25.6 ng/mL, and vitamin D deficiency (25(OH)D <20 ng/mL) was observed in 29 subjects (24.8%). In those with vitamin D deficiency, we found a non-significant trend towards lower antibody-titers at T3, and significantly lower titers at T4 as compared to those not vitamin D-deficient, also observing a more pronounced antibody-titers negative drop from peak-T2 and T4 in those with vitamin D deficiency. A positive correlation between 25(OH)D levels and antibody-titers at T4 (p = 0.043) was found. In multiple linear-regression analysis, 25(OH)D deficiency and older-age resulted as negative independent factors associated with antibody titer at T4 (p = 0.026, p = 0.004; respectively).


In our relatively young cohort presenting low prevalence of hypovitaminosis D, the long-term humoral response to anti-SARS-CoV-2 vaccination was negatively influenced by low baseline 25(OH)D. Vitamin D supplementation could be tested as a strategy to optimize the vaccination campaigns to prevent severe COVID-19.

Reference:

di Filippo, L., Frara, S., Terenzi, U. et al. Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination. Endocrine (2023). https://doi.org/10.1007/s12020-023-03481-w

Keywords:

Low, Vitamin D, levels, associated, low, COVID-19, vaccine, antibody, titers, among, adults, Endocrine, di Filippo, L., Frara, S., Terenzi, U.

Tags:    
Article Source : Endocrine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News